ATM and pancreatic neoplasm: In this study, one (0.9%) pathogenic germline ATM variant in the French-Canadian series and three (1.3%) pathogenic germline ATM variants in the Quebec pancreas cancer study series were identified, consistent with the findings of other studies [32].